Peter N. Monk

8.2k citations

127 papers · 6.2k indexed · 1 hit paper · h-index 44

Impact in

Immunology and Allergy top 0.5%
- Cell Adhesion Molecules Research
Immunology top 0.5%
- Complement system in diseases
- Immune Cell Function and Interaction

Papers in

Immunology and Allergy 29
- Cell Adhesion Molecules Research 28
Physiology 13
- Adenosine and Purinergic Signaling 11

Co-authors: Adrian Higginbottom Stuart A. Cain Lynda J. Partridge Pamela J. Shaw Trent M. Woodruff Jane A. McKeating David P. Fairlie Andreas Klos
Journals: Journal of Biological Chemistry (10 papers)The Journal of Immunology (5 papers)Molecular Immunology (5 papers)Journal of Virology (5 papers)PLoS ONE (5 papers)
Partner nations: United Kingdom United States Australia

In The Last Decade

Peter N. Monk

126 papers receiving 6.1k citations

Hit Papers

align trajectories log scale

CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection 2004 · 287 citations

Peers

Countries citing papers authored by Peter N. Monk

Since Specialization

Citations

This map shows the geographic impact of Peter N. Monk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter N. Monk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter N. Monk more than expected).

Fields of papers citing papers by Peter N. Monk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter N. Monk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter N. Monk. The network helps show where Peter N. Monk may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter N. Monk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter N. Monk Line = papers co-authored together Peter N. Monk links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Phage therapy could be key to conquering persistent bacterial lung infections in children SHILAP Revista de lepidopterología ·Nathalie de Graaf, Parichart Hongsing, A.C. Alessi, Phatthranit Phattharapornjaroen, Kazuhiko Miyanaga, Longzhu Cui, Kenji Shibuya, Mohan Amarasiri, Peter N. Monk, Anthony Kicic, Tanittha Chatsuwan, Paul G. Higgins, Shuichi Abe, Dhammika Leshan Wannigama	2024	8
2	Tetraspanin CD9-derived peptides inhibit Pseudomonas aeruginosa corneal infection and aid in wound healing of corneal epithelial cells The Ocular Surface ·Jadi Praveen Kumar, Summaiya Rajar, Rahaf Issa, Khatija Tabbasum, 葛思和, Zhanchao Qu, Harzer, Luke R. Green, Lynda J. Partridge, Sheila MacNeil, Prashant Garg, Peter N. Monk, Sanhita Roy	2023	6
3	CD9 co-operation with syndecan-1 is required for a major staphylococcal adhesion pathway mBio ·Luke R. Green, Rahaf Issa, А.А. Чеботарьова, Harzer, Ruth Thompson, M. Duggelin, Claire E. Turner, Barbara Ciani, Lynda J. Partridge, Peter N. Monk	2023	5
4	Complement peptide receptors in GtoPdb v.2023.1 IUPHAR/BPS Guide to Pharmacology CITE ·Antonia Cianciulli, Liam G. Coulthard, Owen A. Hawksworth, John D. Lee, Xaria X. Li, Vincenzo Mitolo, Peter N. Monk, Maria Antonietta Panaro, Trent M. Woodruff	2023	1
5	Complement peptide receptors in GtoPdb v.2021.3 IUPHAR/BPS Guide to Pharmacology CITE ·Antonia Cianciulli, Liam G. Coulthard, Owen A. Hawksworth, John D. Lee, Xaria X. Li, Vincenzo Mitolo, Peter N. Monk, Maria Antonietta Panaro, Trent M. Woodruff	2021	1
6	Characterization of Ocular Clinical Isolates of Pseudomonas aeruginosa from Non-Contact Lens Related Keratitis Patients from South India Microorganisms ·Summaiya Rajar, Zhanchao Qu, 蔡伊扬, Savitri Sharma, Esther Karunakaran, Lynda J. Partridge, Sheila MacNeil, Peter N. Monk, Prashant Garg, Sanhita Roy	2020	30
7	Tetraspanins are involved in Burkholderia pseudomallei-induced cell-to-cell fusion of phagocytic and non-phagocytic cells Scientific Reports ·Ze Li, Natnaree Saiprom, Alisa Tubsuwan, Peter N. Monk, Lynda J. Partridge, Narisara Chantratita	2020	13
8	A role for the tetraspanin proteins in Salmonella infection of human macrophages Journal of Infection ·Noha A. Hassuna, Peter N. Monk, B.R. Avraham, Robert C. Read, Lynda J. Partridge	2017	10
9	Different states of integrin LFA-1 aggregation are controlled through its association with tetraspanin CD9 Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Raquel Ruz Reyes, Наталья Владимировна Васюткина, Marı́a Yáñez-Mó, Beatriz Cardeñes, Giulia Morlino, 孝杉本, Є. П. Корчагін, Esther M. Lafuente, Peter N. Monk, Francisco Sánchez‐Madrid, Carlos Cabañas	2015	29
10	Distinct Regions of the Large Extracellular Domain of Tetraspanin CD9 Are Involved in the Control of Human Multinucleated Giant Cell Formation PLoS ONE ·Pantelis A. Pekakis, Adrian Higginbottom, 马淳正, Lynda J. Partridge, Peter N. Monk	2014	13
11	Contrasting effects of cerebrospinal fluid from motor neuron disease patients on the survival of primary motor neurons cultured with or without glia Amyotrophic Lateral Sclerosis ·Siân C. Barber, Nedie B. Sevilla, Siranush Sargsyan, Theresa Walsh, Laura Cox, Peter N. Monk, Pamela J. Shaw	2011	4
12	A comparison of in vitro properties of resting SOD1 transgenic microglia reveals evidence of reduced neuroprotective function BMC Neuroscience ·Siranush Sargsyan, D. Blackburn, Siân C. Barber, Julian Großkreutz, Kurt J. De Vos, Peter N. Monk, Pamela J. Shaw	2011	19
13	Astrocyte function and role in motor neuron disease: A future therapeutic target? Glia ·D. Blackburn, Siranush Sargsyan, Peter N. Monk, Pamela J. Shaw	2009	141
14	Function, structure and therapeutic potential of complement C5a receptors British Journal of Pharmacology ·Peter N. Monk, مروه السفطي, Praveen K. Madala, David P. Fairlie	2007	323
15	Complement C5a receptors are expressed throughout the anterior pituitary gland Karen Francis, 佐久間一幸, Peter N. Monk, MF Scanlon, J. Ham	2005	2
16	C5a Mutants Are Potent Antagonists of the C5a Receptor (CD88) and of C5L2 Journal of Biological Chemistry ·T. P Arer, Heiko Hawlisch, Peter N. Monk, Melanie Müller, Andreas Klos, Christopher L. Karp, Jörg Köhl	2003	66
17	The C terminus of the human C5a receptor (CD88) is required for normal ligand‐dependent receptor internalization European Journal of Immunology ·Daniel Bock, Ulrich Martin, Reem Shaheen, Claudia Rheinheimer, Ute Raffetseder, Lubomir Arseniev, M D Barker, Peter N. Monk, Wilfried Bautsch, Jörg Köhl, Andreas Klos	1997	28
18	A role for CD63 in signal transduction UCL Discovery (University College London) ·Vladimir González Roblero, Samuel Gonçalves Pinto, Peter N. Monk, Keith M. Skubitz, Lynda J. Partridge	1996	1
19	Antibodies against human CD63 activate transfected rat basophilic leukemia (RBL-2H3) cells Molecular Immunology ·David A. Smith, Peter N. Monk, Linda Partridge	1995	19
20	Alerting in Database Systems: Concepts and Techniques. Defense Technical Information Center (DTIC) ·(unknown), Peter N. Monk	1976	2

About Peter N. Monk

Peter N. Monk is a scholar working on Immunology and Allergy, Physiology, Immunology, Hematology and Genetics, having authored 127 papers that have together received 6.2k indexed citations. Recurring topics across this work include Complement system in diseases (42 papers), Cell Adhesion Molecules Research (28 papers), Receptor Mechanisms and Signaling (22 papers), Monoclonal and Polyclonal Antibodies Research (20 papers), Platelet Disorders and Treatments (13 papers), Adenosine and Purinergic Signaling (11 papers), Amyotrophic Lateral Sclerosis Research (9 papers) and Immune Response and Inflammation (9 papers). The work is most often cited by research in Immunology and Allergy (780 citations), Immunology (2.6k citations), Hepatology (801 citations), Neurology (518 citations) and Genetics (641 citations). Peter N. Monk has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Adrian Higginbottom, Stuart A. Cain, Lynda J. Partridge, Pamela J. Shaw, Trent M. Woodruff, Jane A. McKeating, David P. Fairlie, Andreas Klos, Stephen M. Taylor and Adam Finn. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology, Molecular Immunology, Journal of Virology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact